This third volume of Kalorama Information’s World Market for Anti-Infectives series, the 2nd. Edition focuses on three general product segments of antiviral treatment:
- Nucleoside Analogs
- Protease Inhibitors
- Other Misc. Antivirals
The report covers both currently marketed and late stage development antiviral products in detail. For each segment, the report provides:
- Revenue Data by Infection Type
- An overview of products on the market
- Review of products in the development pipeline
- Market estimates and forecasts through 2011
- Market segmentation by geographic region
- Market share of leading suppliers
- Market share of leading products
The report also includes statistical (epidemiologic and demographic) information for viral infections by type worldwide, with special emphasis on the United States and describes the major clinical, business, and regulatory trends shaping the global and domestic markets.
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. In addition, Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers’ level as of 2006. Compound annual growth rates (CAGRs) are provided for 2006-2011 periods for each industry segment covered. Competitive analysis is provided for the year 2006. The forecasted market analysis for 2006-2011 was based on probability of approval and sales of products in late stage development, product marketing, and demographic trends.